Summary & Overview
CPT 0504U: Urinary Tract Infection Multiplex PCR Test
CPT code 0504U designates a proprietary multiplex molecular test from NxGen MDx LLC for Urinary Tract Infection (UTI) detection using real–time PCR. The assay screens urine specimens for 17 pathogenic organisms and reports each pathogen as present or absent. As a PLA code, 0504U is unique to a single manufacturer’s test and is used to identify and track utilization of this specific diagnostic service nationally.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for multiplex PCR UTI testing, expected sites of service, and the implications of PLA designation for coding and payer recognition. The publication outlines typical coverage considerations, common modifiers used with laboratory services, and areas where payers may differ in policy approaches.
This summary helps clinicians, lab administrators, and coding professionals understand what CPT code 0504U represents, why PLA status matters for billing and data capture, and what to expect in terms of payer engagement and policy attention at a national level.
Billing Code Overview
CPT code 0504U is a Proprietary Laboratory Analyses (PLA) code that applies solely to a specific laboratory test from NxGen MDx LLC. The code is reported only for Urinary Tract Infection Testing performed by NxGen MDx LLC.
The test uses real–time polymerase chain reaction (PCR) to detect 17 pathogenic organisms in urine samples. Results are reported as presence or absence for each organism tested.
Service type: Laboratory—molecular diagnostic testing (proprietary multiplex PCR assay)
Typical site of service: Clinical laboratory or other certified laboratory facility processing patient urine specimens
Clinical & Coding Specifications
Clinical Context
A 34-year-old female presents to an outpatient urology clinic with dysuria, urinary frequency, and suprapubic discomfort for 48 hours. The clinician collects a clean-catch urine specimen and orders a multiplex real–time PCR urine panel to detect common bacterial and viral urinary pathogens. The specimen is sent to the performing laboratory (NxGen MDx LLC) using approved specimen transport. The laboratory performs the proprietary assay and reports presence/absence for 17 pathogenic organisms. Results are returned to the ordering clinician who integrates findings with urinalysis, patient symptoms, and prior culture results to guide antimicrobial selection or further evaluation for complicated urinary tract infection.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Default reporting when no modifier applies |
26 | Professional component | Use if reporting the professional interpretation separate from the technical component |
TC |